These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 2091058)
21. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation. Demanes DJ; Brandt D; Schour L; Hill DR Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902 [TBL] [Abstract][Full Text] [Related]
22. [Contribution of curietherapy in the treatment of ENT tumors]. Beauvois S Rev Med Brux; 1996 Apr; 17(2):86-90. PubMed ID: 8685553 [TBL] [Abstract][Full Text] [Related]
23. High-dose-rate brachytherapy for large prostate volumes (> or =50cc)-Uncompromised dosimetric coverage and acceptable toxicity. Monroe AT; Faricy PO; Jennings SB; Biggers RD; Gibbs GL; Peddada AV Brachytherapy; 2008; 7(1):7-11. PubMed ID: 18299109 [TBL] [Abstract][Full Text] [Related]
24. Recent advances in radiation therapy. Gerber DE; Chan TA Am Fam Physician; 2008 Dec; 78(11):1254-62. PubMed ID: 19069018 [TBL] [Abstract][Full Text] [Related]
25. Electronic brachytherapy: comparisons with external-beam and high-dose-rate 192Ir brachytherapy. Holt RW; Rivard MJ J Am Coll Radiol; 2008 Mar; 5(3):221-3. PubMed ID: 18312972 [No Abstract] [Full Text] [Related]
27. Controversies in prostate cancer radiotherapy: consensus development. Lukka H; Warde P; Pickles T; Morton G; Brundage M; Souhami L; Can J Urol; 2001 Aug; 8(4):1314-22. PubMed ID: 11564274 [TBL] [Abstract][Full Text] [Related]
28. [Therapeutic ratio in radiotherapy--clinical analysis and strategy]. Okawa T; Kita M; Goto M Gan No Rinsho; 1987 Oct; 33(13):1527-31. PubMed ID: 3694791 [TBL] [Abstract][Full Text] [Related]
29. External beam radiotherapy and high dose rate brachytherapy for medically unfit and elderly patients. Marijnen CA Clin Oncol (R Coll Radiol); 2007 Nov; 19(9):706-10. PubMed ID: 17826039 [TBL] [Abstract][Full Text] [Related]
30. [ORL brachytherapy. Brachytherapy of epidermoid carcinoma of the oral cavity]. Haie-Meder C; Marsiglia H; Mamelle G; Wibault P; Lartigau E; Gerbaulet A Bull Cancer Radiother; 1995; 82(2):186-90. PubMed ID: 7546889 [No Abstract] [Full Text] [Related]
31. [Radiotherapy and curietherapy of squamous cell carcinoma of the posterior pharyngeal wall (excluding the nasopharynx)]. Chenal C; Julienne V; Fleury F; Desprez P Bull Cancer Radiother; 1996; 83(1):54-9. PubMed ID: 8679282 [TBL] [Abstract][Full Text] [Related]
32. Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy. Zelefsky MJ; Nedelka MA; Arican ZL; Yamada Y; Cohen GN; Shippy AM; Park JJ; Zaider M Brachytherapy; 2008; 7(1):1-6. PubMed ID: 18299108 [TBL] [Abstract][Full Text] [Related]
33. [Value of the combination of external radiotherapy and curietherapy in carcinoma of the velo-tonsillar region. Statistical study of a series of 361 patients]. Pernot M; Hoffstetter S; Malissard L; Luporsi E; Peiffert D; Aletti P; Marchal C; Kozminski P; Bey P Bull Cancer Radiother; 1996; 83(1):40-6. PubMed ID: 8679280 [TBL] [Abstract][Full Text] [Related]
34. Monotherapeutic brachytherapy for clinically organ-confined prostate cancer. Merrick GS; Butler WM; Wallner KE; Galbreath RW; Adamovich E W V Med J; 2005; 101(4):168-71. PubMed ID: 16296198 [TBL] [Abstract][Full Text] [Related]
35. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience. Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997 [TBL] [Abstract][Full Text] [Related]
36. Challenge of dose escalation in locally advanced unfavourable prostate cancer using HDR brachytherapy. Al-Salihi O; Mitra A; Payne H Prostate Cancer Prostatic Dis; 2006; 9(4):370-3. PubMed ID: 16832383 [TBL] [Abstract][Full Text] [Related]
37. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839 [TBL] [Abstract][Full Text] [Related]